Point-of-care testing for respiratory infections during and after COVID-19

The public’s attitude to testing is likely to change in response to SARS-CoV-2 testing. We expect it will not be long before we are asked why tests are not offered for other respiratory infections. Prior to COVID-19, the initial management of most respiratory tract infections (RTIs) was conducted without microbiological testing, with many suggesting the consequent diagnostic uncertainty to be a leading cause of antibiotic overprescribing and resistance. Standard laboratory methods are too slow for initial decision making necessitating the use of rapid point-of-care testing. This technology, advocated as key to future antimicrobial stewardship, is now available and able to provide comprehensive respiratory virus panel results, including SARS-CoV-2, in 45 minutes.